SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-073608
Filing Date
2015-10-28
Accepted
2015-10-28 16:45:00
Documents
4
Period of Report
2015-10-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-21610_18k.htm 8-K 31862
2 EX-3.6 a15-21610_1ex3d6.htm EX-3.6 141320
3 EX-99.1 a15-21610_1ex99d1.htm EX-99.1 316386
4 GRAPHIC g216101mm01i001.jpg GRAPHIC 3464
  Complete submission text file 0001104659-15-073608.txt   495803
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 151180736
SIC: 2834 Pharmaceutical Preparations